Favorite thing to do while blasted?
Patient reports that their favorite activity remains “absolutely nothing,” which, clinically speaking, is a legitimate therapeutic endpoint. Via r/trees Further Reading Research DigestAM Policy Update: March 11, 2026 Cannabis Policy…
Cannabinoid Clinical Trials: CBD for Fibromyalgia Pain
This randomized, double-blind, placebo-controlled trial evaluated CBD for fibromyalgia pain. Results showed CBD did not outperform placebo in reducing pain intensity. These findings highlight the need for cautious interpretation of CBD for fibromyalgia…
Endocannabinoid System Clinical Research: Eating Disorders
This article covers endocannabinoid system adolescent eating disorder research focusing on how adolescent risk factors contribute to eating disorders. The study highlights the importance of early screening for disordered eating and body image concerns.…
After a Decade of Growth, Legal Cannabis Declined in 2025
The legal cannabis market contraction 2025 marks a significant shift after years of growth. This change affects patient access, pricing, and the potential for expanded federally-funded cannabis research. Clinicians must stay informed about these…
NC Hemp Shop Owners Fear Industry Collapse Amid Regulatory Changes
Hemp industry regulatory changes are causing significant disruption for North Carolina retailers and patients. These changes threaten the legal status of hemp-derived cannabinoid products, impacting access and compliance. Clinicians must understand these…
Michigan Supreme Court Asked to Rule on Marijuana Use and Probation
The Michigan Supreme Court is reviewing marijuana use and probation conditions amid state legalization. This case highlights conflicts between legal cannabis use and probation restrictions. Clinicians must understand these legal issues to advise patients…
How Excessive Cannabis Taxes Fuel the Illicit Market
Excessive cannabis taxation impacts patient access by driving consumers to the illicit market. This shift increases risks due to unregulated products lacking quality control. Clinicians must counsel patients on these dangers and advocate for balanced tax…
RAAF Veteran Launches Fundraising Drive for Cannabis-Based Symptom Management
This article highlights cannabis-based symptom management emerging in veteran healthcare amid DVA framework changes. Veterans with PTSD and chronic pain may benefit from evolving cannabis therapies. Clinicians should stay informed about these changes to…
New Texas THC Rules Could Ban Smokable Hemp by March 31
Texas hemp rules smokable hemp ban will affect patient access to smokable hemp products by March 31. Clinicians must understand these changes for effective treatment discussions. The new regulations shift THC measurement standards impacting legal hemp…
CED Digest: 392 Items — March 11, 2026
The CED Digest for March 11, 2026, highlights cannabis compounds CBD and CBG with potential therapeutic effects. These cannabinoids may help reduce fatty liver disease and improve metabolic health. Clinicians can consider this evidence when advising…
